REVIEW PAPER
COVID-19 among HIV-infected population
1
Department of Internal Medicine, Wangaya Regional General Hospital, Denpasar, Indonesia
2
Department of Dermatology, Wangaya Regional General Hospital, Denpasar, Indonesia
Submission date: 2020-12-14
Acceptance date: 2021-03-23
Publication date: 2021-12-26
HIV & AIDS Review 2021;20(4):231-234
KEYWORDS
TOPICS
ABSTRACT
Novel coronavirus disease 2019, COVID-19, has been declared as a pandemic on March 11th, 2020. The devastating impact of COVID-19 has affected every sectors and individuals worldwide. No definite and specific treatment has been discovered up till now, apart from symptomatic or experimental treatments. Individuals with chronic disease comorbidity are identified to have worse outcomes and greater risk of mortality. Moreover, certain chronic infectious disease, such as human immunodeficiency virus (HIV), is also included as affected individuals by COVID-19 with unknown extent. Various recent studies suggested that there is no higher risk of COVID-19 among HIV-infected population, but subjects are limited. Additionally, controversies still exist regarding the outcome of COVID-19 in HIV-
infected population as well as the role of antiretroviral therapy (ART) in COVID-19. Another problems regarding COVID-19 pandemic in this context impede medical access and disturb adherence to ART in HIV patients, further increasing risk of lethal morbidity and mortality of COVID-19.
Because of the urgency of COVID-19 pandemic as well as chronicity, mortality, and great number of HIV infections, clinicians should be aware of the relationship between HIV infection and COVID-19. This review article summarized the association between HIV infection and COVID-19 during the pandemic, including the current evidence of ART in COVID-19.
infected population as well as the role of antiretroviral therapy (ART) in COVID-19. Another problems regarding COVID-19 pandemic in this context impede medical access and disturb adherence to ART in HIV patients, further increasing risk of lethal morbidity and mortality of COVID-19.
Because of the urgency of COVID-19 pandemic as well as chronicity, mortality, and great number of HIV infections, clinicians should be aware of the relationship between HIV infection and COVID-19. This review article summarized the association between HIV infection and COVID-19 during the pandemic, including the current evidence of ART in COVID-19.
REFERENCES (38)
1.
Mirzaei H, McFarland W, Karamouzian M, Sharifi H. COVID-19 among people living with hiv: a systematic review. AIDS Behav 2021; 25: 85-92.
2.
Karmen-Tuohy S, Carlucci PM, Zervou FN, et al. Outcomes among HIV-positive patients hospitalized with COVID-19. J Acquir Immune Defic Syndr 2020; 85: 6-10.
4.
Inciarte A, Gonzalez-Cordon A, Rojas J, et al. Clinical characteristics, risk factors, and incidence of symptomatic coronavirus disease 2019 in a large cohort of adults living with HIV: a single-center, prospective observational study. AIDS 2020; 34: 1775-1780.
5.
Shiau S, Krause KD, Valera P, Swaminathan S, Halkitis PN. The burden of COVID-19 in people living with HIV: a syndemic perspective.
7.
Xu Z, Zhang C, Wang FS. COVID-19 in people with HIV. Lancet HIV 2020; 7: e524-526.
9.
19 in HIV-infected individuals: a single-centre, prospective cohort. Lancet HIV 2020; 7: e554-564.
10.
Guo W, Ming F, Dong Y, et al. A survey for COVID-19 among HIV/AIDS patients in two districts of Wuhan, China. SSRN Electron J [Internet]; 2020. Available from: https://www.ssrn.com/abstract=... (Accessed: 06.10.2020).
11.
Dandachi D, Geiger G, Montgomery MW, et al. Characteristics, comorbidities, and outcomes in a multicenter registry of patients with HIV and coronavirus disease-19. Clin Infect Dis 2021; 73: e1964-e1972.
13.
reflect the severity of infection and predict the clinical outcomes in patients with COVID-19. J Infect 2020; 81: 318-356.
14.
Zhang H, Wu T. CD4+T, CD8+T counts and severe COVID-19: a meta-analysis. J Infect 2020; 81: e82-e84.
15.
Gervasoni C, Meraviglia P, Riva A, et al. Clinical features and outcomes of patients with human immunodeficiency virus with.
17.
EACS (European AIDS Clnical Society) and BHIVA. Statement on risk of COVID-19 for people living with HIV (EACS & BHIVA) [Internet]; 2020. Available from: https://www.eacsociety.org/hom... (Accessed: 04.10.2020).
18.
Davies MA. HIV and risk of COVID-19 death: a population cohort study from the Western Cape Province, South Africa. MedRxiv 2020. doi: 10.1101/2020.07.02.20145185. Preprint.
19.
Beyrer C. Consolidated guidelines on HIV prevention, diagnosis, treatment and care for key populations [Internet]. Place of publication not identified: World Health Organization; 2016. Available from: http://proxy.library.carleton.... (Accessed: 05.10.2020).
20.
Zhou Y, Vedantham P, Lu K, et al. Protease inhibitors targeting coronavirus and filovirus entry. Antiviral Res 2015; 116: 76-84.
21.
de Wilde AH, Jochmans D, Posthuma CC, et al. Screening of an FDA-approved compound library identifies four small-molecule inhibitors of Middle East respiratory syndrome coronavirus replication in cell culture. Antimicrob Agents Chemother 2014; 58: 4875-4884.
22.
Chan JFW, Yao Y, Yeung ML, et al. Treatment with lopinavir/ritonavir or interferon-β1b improves outcome of MERS-CoV infection in a nonhuman primate model of common marmoset. J Infect Dis 2015; 212: 1904-1913.
23.
Cao B, Wang Y, Wen D, et al. A trial of lopinavir–ritonavir in adults hospitalized with severe COVID-19. N Engl J Med 2020; 382: 1787-1799.
24.
Elfiky AA. Ribavirin, remdesivir, sofosbuvir, galidesivir, and tenofovir against SARS-CoV-2 RNA dependent RNA polymerase (RdRp): a molecular docking study. Life Sci 2020; 253: 117592.
26.
COVID-19 in HIV-positive persons receiving antiretroviral therapy: a cohort study. Ann Intern Med 2020; 173: 536-541.
27.
Härter G, Spinner CD, Roider J, et al. COVID-19 in people living with human immunodeficiency virus: a case series of 33 patients. Infection 2020; 48: 681-686.
28.
Byrd KM, Beckwith CG, Garland JM, et al. SARS‐CoV‐2 and HIV coinfection: clinical experience from Rhode Island, United States.
29.
J Int AIDS Soc [Internet]; 2020. Available from: https://onlinelibrary.wiley.co... (Accessed: 05.10.2020).
30.
Richardson S, Hirsch JS, Narasimhan M, et al. Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized with COVID-19 in the New York City area. JAMA 2020; 323: 2052-2059.
31.
Borobia A, Carcas A, Arnalich F, et al. A cohort of patients with COVID-19 in a major teaching hospital in Europe. J Clin Med 2020; 9: 1733.
32.
Ridgway JP, Farley B, Benoit JL, et al. A case series of five people living with HIV hospitalized with COVID-19 in Chicago, Illinois. AIDS Patient Care STDs 2020; 34: 331-335.
33.
Marimuthu J, Kumar BS, Aravind Gandhi P. HIV and SARS CoV‐2 co‐infection: a retrospective, record based, case series from South India. J Med Virol 2021; 93: 163-165.
34.
National Institute of Health. Interim Guidance for COVID-19 and Persons with HIV. In 2020. Available from: https://clinicalinfo.hiv.gov/e....
36.
COVID-19 in Health Care Personnel in Colombia [Internet]. Avail able from: https://clinicaltrials.gov/ct2... (Accessed: 04.10.2010).
37.
Randomized Clinical Trial for the Prevention of SARS-CoV-2 Infection (COVID-19) in Healthcare Personnel (EPICOS) [Internet]. Available from: https://clinicaltrials.gov/ct2... (Accessed: 03.10.2010).
38.
Efficacy and Safety of Darunavir and Cobicistat for Treatment of COVID-19 (DC-COVID-19) [Internet]. Available from: https://clinicaltrials.gov/ct2... (Accessed: 04.10.2010).
Share
RELATED ARTICLE
| eISSN: | 1732-2707 |
| ISSN: | 1730-1270 |
We process personal data collected when visiting the website. The function of obtaining information about users and their behavior is carried out by voluntarily entered information in forms and saving cookies in end devices. Data, including cookies, are used to provide services, improve the user experience and to analyze the traffic in accordance with the Privacy policy. Data are also collected and processed by Google Analytics tool (more).
You can change cookies settings in your browser. Restricted use of cookies in the browser configuration may affect some functionalities of the website.
You can change cookies settings in your browser. Restricted use of cookies in the browser configuration may affect some functionalities of the website.
